Hemocontrol's Effectiveness on the Reduction of Cardiovascular Long-term EventS

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 396 participants.

Also called NCT01515878

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 396 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01515878
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada, France, Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01515878. Randomized; no masking; primary purpose prevention. Start 2012-02 (registry gives no type); primary completion 2015-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Hemocontrol's Effectiveness on the Reduction of Cardiovascular Long-term EventS
Acronym
HERACLES
Condition
Kidney Failure Chronic
Condition
Cardiovascular Diseases
Intervention (Device)
Hemocontrol
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna (class: other)

Record details

Record id
cardio:ct-nct01515878
Content hash
cc851816ec099ade98931f89941df6af67038e4ed1f1607dd412965ea3d51e2b